Skip to content

Evolent Health, Inc. EVH Return on equity

Return on equity at other companies

CVS Health logo
CVS HealthCVS
3.8%-3.2pp
UnitedHealth Group logo
UnitedHealth GroupUNH
11.8%-11.1pp
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
-277.6%-700pp
Astrana Health logo
Astrana HealthASTH
3.9%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
16.9%
Elevance Health logo
Elevance HealthELV
12.1%-2.1pp

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Calculated from Evolent Health, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s return on equity?
Evolent Health, Inc. (EVH) reported return on equity of -74.6% in Q1 2026.
How has Evolent Health, Inc.'s return on equity changed year-over-year?
Evolent Health, Inc.'s return on equity decreased by 578.6% year-over-year, from -11% to -74.6%.
What is the long-term trend for Evolent Health, Inc.'s return on equity?
Over 5 years (2020 to 2025), Evolent Health, Inc.'s return on equity has grown at a 11.8% compound annual growth rate (CAGR), from -43.2% to -75.5%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.